机构：[1]Department of Clinical Pharmacy and Pharmacy Administration, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, China[2]Department of Pharmacy, Sichuan Cancer Hospital & Institution, Sichuan Cancer Center, Chengdu, Sichuan, China临床药学部临床药学部四川省肿瘤医院
第一作者机构：[1]Department of Clinical Pharmacy and Pharmacy Administration, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, China
推荐引用方式(GB/T 7714)：
Yang Yujie,Wang Yanran,Wang Ting,et al.Screening active components of Modified Xiaoyao Powder for chemoprevention in breast cancer cells: Involvement of the NRF2/NQO1 signalling pathway[J].BIOCHEMICAL PHARMACOLOGY.2017,139:117-118.doi:10.1016/j.bcp.2017.06.091.
APA：
Yang, Yujie,Wang, Yanran,Wang, Ting&Jiang, Xuehua.(2017).Screening active components of Modified Xiaoyao Powder for chemoprevention in breast cancer cells: Involvement of the NRF2/NQO1 signalling pathway.BIOCHEMICAL PHARMACOLOGY,139,
MLA：
Yang, Yujie,et al."Screening active components of Modified Xiaoyao Powder for chemoprevention in breast cancer cells: Involvement of the NRF2/NQO1 signalling pathway".BIOCHEMICAL PHARMACOLOGY 139.(2017):117-118
医学